Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 2127749)

Published in Eur J Clin Invest on December 01, 1990

Authors

M J Savolainen1, M Hannuksela, S Seppänen, K Kervinen, Y A Kesäniemi

Author Affiliations

1: Department of Internal Medicine, University of Oulu, Finland.

Articles by these authors

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18

Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25

Association between dental health and acute myocardial infarction. BMJ (1989) 3.94

Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol (1990) 2.56

Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ (1998) 2.16

Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens (1998) 2.02

Finnish Allergy Programme 2008-2018--time to act and change the course. Allergy (2008) 2.02

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ (1997) 1.97

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. Circulation (1997) 1.89

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia (2010) 1.88

Transarterial embolization of a direct carotid cavernous fistula with Guglielmi detachable coils. AJNR Am J Neuroradiol (1997) 1.72

Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest (2001) 1.54

Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology (1996) 1.54

Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation (1996) 1.50

Apolipoprotein B gene polymorphisms and serum lipids: meta-analysis of the role of genetic variation in responsiveness to diet. Am J Clin Nutr (2000) 1.47

Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology (2006) 1.45

Apolipoprotein E phenotype and blood pressure. Lancet (1994) 1.45

Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism (1989) 1.33

Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J (2004) 1.32

Decline in out-of-hospital coronary heart disease deaths has contributed the main part to the overall decline in coronary heart disease mortality rates among persons 35 to 64 years of age in Finland: the FINAMI study. Circulation (2003) 1.31

Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma. Scand J Clin Lab Invest (1969) 1.30

Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ (1994) 1.29

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med (1999) 1.27

Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis (1994) 1.25

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest (1987) 1.25

A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men. Life Sci (1991) 1.24

Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest (1999) 1.24

Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart (1996) 1.17

Assessment of skin erythema by eye, laser Doppler flowmeter, spectroradiometer, two-channel erythema meter and Minolta chroma meter. Arch Dermatol Res (1993) 1.16

Syphilis of the spine. Br J Vener Dis (1972) 1.15

Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res (1995) 1.14

Antibodies to Epstein-Barr virus and some other herpesviruses in patients with sarcoidosis, pulmonary tuberculosis and erythema nodosum. Scand J Infect Dis (1974) 1.14

The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study. Circulation (2000) 1.13

Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med (2001) 1.10

Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol (1995) 1.10

Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med (2000) 1.09

1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res (1994) 1.07

Ultraviolet light therapy in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) (1985) 1.07

Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins. J Clin Invest (1985) 1.06

Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease. J Clin Invest (1985) 1.06

Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett (1996) 1.05

Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med (2005) 1.03

Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res (1992) 1.03

Trends in coronary events in Finland during 1983-1997. The FINAMI study. Eur Heart J (2003) 1.02

Epicutaneous testing. Allergy (1979) 1.02

Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol (1995) 1.01

Erythema nodosum due to Yersinia enterocolitica. Scand J Infect Dis (1969) 1.01

Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Community Health (2000) 1.01

Collagen metabolism of the skin in Marfan's syndrome. Clin Chim Acta (1968) 1.00

Nodules on the legs. A clinical, histological and immunohistological study of 82 patients representing different types of nodular panniculitis. Acta Derm Venereol (1977) 0.99

Carbamylation-induced alterations in low-density lipoprotein metabolism. Kidney Int (1992) 0.98

Apolipoprotein E phenotype alone does not influence survival in Alzheimer's disease: a population-based longitudinal study. Neuroepidemiology (2000) 0.98

Polymorphisms of key enzymes in homocysteine metabolism affect diet responsiveness of plasma homocysteine in healthy women. J Nutr (2001) 0.98

Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med (2002) 0.98

Trioxsalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol (1978) 0.97

Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr (1989) 0.97

Microcatheter embolization of intractable idiopathic epistaxis. Cardiovasc Intervent Radiol (2000) 0.97

Solubility and turnover of collagen in collagen diseases. Ann Clin Res (1969) 0.96

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes. J Intern Med (2011) 0.96

Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa. Clin Exp Dermatol (1981) 0.95

Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. JAMA (1984) 0.95

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis (1998) 0.95

Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis (1987) 0.94

A multicenter study of patch test reactions with dental screening series. Am J Contact Dermat (2001) 0.94

Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein. Eur J Clin Invest (1994) 0.94

Caustic ulcers caused by cement. Br J Dermatol (1976) 0.94

Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers. Arterioscler Thromb Vasc Biol (1997) 0.93

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis (1993) 0.92

Fall-related brain injuries and the risk of dementia in elderly people: a population-based study. Eur J Neurol (2005) 0.92

Cardiovascular disease and hyperlipidaemia. Curr Opin Lipidol (1994) 0.92

Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome. Am J Hypertens (1998) 0.92

Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur J Endocrinol (2007) 0.92

Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey. Clin Exp Immunol (2011) 0.92

Urticaria from alcoholic beverages. Acta Allergol (1976) 0.91

Corticosteroid allergy in asthma. Allergy (2003) 0.91

Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males. J Intern Med (2006) 0.91

Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology (1993) 0.91

Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand J Clin Lab Invest (2008) 0.91

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism (1992) 0.90

Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis (1994) 0.90

Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia (2005) 0.90

Adrenal pheochromocytoma-ganglioneuroma producing catecholamines and various neuropeptides. Acta Med Scand (1988) 0.90

Contact urticaria from protein hydrolysates in hair conditioners. Allergy (1998) 0.90